Nanomatrix Coated Stent Enhances Endothelialization but Reduces Platelet, Smooth Muscle Cell, and Monocyte Adhesion...

Area of Science:

• Biomaterials Science
• Cardiovascular Research
• Nanotechnology

Background:

• Cardiovascular disease is the leading global cause of death.
• Current cardiovascular stents have significant limitations, including restenosis, neointimal hyperplasia, thrombosis, inflammation, and poor re-endothelialization.
• There is a critical need for improved stent technologies to enhance patient outcomes.

Purpose of the Study:

• To evaluate a novel peptide amphiphile-based nanomatrix coating for cardiovascular stents.
• To assess the stent coating's ability to address multiple shortcomings of current devices simultaneously.
• To investigate the coating's performance under physiological flow conditions in vitro.

Main Methods:

• Development of a biocompatible, multifunctional nanomatrix coating using peptide amphiphiles.
• In vitro evaluation of the nanomatrix-coated stent under physiological flow conditions.
• Assessment of endothelial cell, smooth muscle cell, platelet, and monocyte responses to the coated stent.

Main Results:

• The nanomatrix coating promoted endothelial cell migration, adhesion, and proliferation, indicating potential for improved re-endothelialization.
• The coating inhibited smooth muscle cell migration and adhesion, suggesting a reduced risk of neointimal hyperplasia and restenosis.
• The nanomatrix coating decreased platelet activation and adhesion, showing potential to prevent thrombosis.
• Monocyte adhesion was reduced, indicating an attenuated inflammatory response.

Conclusions:

• The nanomatrix stent coating demonstrates significant potential for clinical utility in treating cardiovascular disease.
• The coating effectively addresses multiple adverse events associated with current stents.
• Biocompatibility, multifunctionality, and bioactivity are crucial for advanced cardiovascular device design.